Mobile fetal monitoring platform from Cerner wins FDA nod

11/14/2012 | Kansas City Star (Mo.), The

The FDA has cleared Cerner to market its FetaLink+ fetal monitoring system. The technology is designed to allow clinicians to use their iPads or iPhones to access fetal and maternal data in near-real time and make informed medical decisions.

View Full Article in:

Kansas City Star (Mo.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL